BIO is the world’s largest biotechnology organization, providing advocacy, business development, and communications services for more than 1,150 members worldwide. Corporate members range from entrepreneurial companies in the process of developing a first product to Fortune 100 multinationals. BIO also represents state and regional biotech associations, academic centers, and service providers to the industry.

Since BIO was formed in 1993, the biology-based, entrepreneurial industry has grown from a small number of companies concentrated in a few cities to an industry that increasingly extends throughout society. Nearly every state courts biotechnology development, as do an increasing number of countries around the world.

WilmerHale Partner Belinda Juran is chair of a panel entitled "What Every Licensing Professional Should Know About University Licensing and Spin-Outs", and will present on Wednesday, June 18, from 2:00 p.m.-3:30 p.m. Speakers on this session also include Josh Distler, Chief Operating Officer, Attenuon, LLC, Dominique Kleyn, Head of BioPharma Business Development, Imperial College Innovations Ltd, Kirsten Leute, Senior Associate, Stanford University Office of Technology Licensing, and Dennis Stone, MD, Vice President of Technology Development, University of Texas, Southwestern Medical Center.

WilmerHale is a sponsor of BIO's Technology Transfer and Licensing two-day track. The firm is also sponsoring an exhibition booth for client and potential client networking and will hold a reception for clients and friends of the firm during the convention.

WilmerHale Partner Belinda Juran was a featured speaker at this event and presented on the topic “What Every Licensing Professional Should Know About University Licensing and Spin-Outs.”